dalteparin has been researched along with Aneurysm, Ruptured in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Aneurysm, Ruptured: The tearing or bursting of the weakened wall of the aneurysmal sac, usually heralded by sudden worsening pain. The great danger of a ruptured aneurysm is the large amount of blood spilling into the surrounding tissues and cavities, causing HEMORRHAGIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After undergoing surgery for a ruptured aneurysm, 170 patients were randomized in a prospective, double-blind, placebo-controlled trial to test the effect of enoxaparin on the occurrence of ischemic lesions, which were demonstrated on follow-up CT scans available for 156 patients." | 2.71 | Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. ( Juvela, S; Porras, M; Poussa, K; Siironen, J; Varis, J, 2005) |
| "Delayed cerebral ischemia (DCI) is one of the major causes of delayed morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH)." | 1.48 | High-Dose Nadroparin Following Endovascular Aneurysm Treatment Benefits Outcome After Aneurysmal Subarachnoid Hemorrhage. ( Berg, RVD; Coert, BA; Post, R; Vandertop, WP; Verbaan, D; Zijlstra, IAJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Post, R | 1 |
| Zijlstra, IAJ | 1 |
| Berg, RVD | 1 |
| Coert, BA | 1 |
| Verbaan, D | 1 |
| Vandertop, WP | 1 |
| Siironen, J | 2 |
| Juvela, S | 2 |
| Varis, J | 2 |
| Porras, M | 2 |
| Poussa, K | 2 |
| Ilveskero, S | 1 |
| Hernesniemi, J | 1 |
| Lassila, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine[NCT04507178] | Phase 2 | 100 participants (Anticipated) | Interventional | 2022-02-02 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for dalteparin and Aneurysm, Ruptured
| Article | Year |
|---|---|
No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Aneurysm, Ruptured; Anticoagulants; Combined Modality Therapy; Double-Blind Method; Enoxaparin; Fema | 2003 |
Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Cerebral Infarction; Double-Blind Method; Enoxapari | 2005 |
1 other study available for dalteparin and Aneurysm, Ruptured
| Article | Year |
|---|---|
High-Dose Nadroparin Following Endovascular Aneurysm Treatment Benefits Outcome After Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Aged; Aneurysm, Ruptured; Brain Ischemia; Embolization, Therapeutic; Endovascular Procedures; | 2018 |